Biopharmaceutical Company.
H.R.5376: Build Back Better Act including H.R.3: Elijah E. Cummings Lower Drug Costs Now Act, and H.R.19. Lower Costs, More Cures Act of 2021. FY 23 IPPS rule as it relates to low volume rare disease therapies. S.4348: FDASLA Act of 2022 and H.R.7667: Food and Drug Amendments of 2022.
MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 2 - HOUSE OF REPRESENTATIVES
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX